Apidra Cartridges are used to improve blood glucose levels for people with type 1 or type 2 diabetes. This fast-acting insulin (similar to NovoLog) helps lower blood sugar levels after meals to avoid any complications related to diabetes mellitus.
Your physician or nurse will provide you with proper methods to apply the injection subcutaneously (under the skin).
This medication should be taken 15 minutes before or within 20 minutes of the beginning of your meal. It will help if you continue using it unless your doctor provides you with different instructions.
Apidra Cartridges can be used along with other diabetes medications, including long-acting types of insulin. Please seek your doctor’s approval before administration. It is quite easy to mix up insulin products, as they usually come in the same form of pens, cartridges and vials. Ensure you are ordering the right type of insulin prescribed to you.
As advised by your physician, Apidra should be used as part of a treatment program in combination with a healthy diet, exercise routine, and weight loss program.
It is essential to check your blood sugar levels regularly, which can be performed using a glucometer. Results should be shared with your doctor so they can adjust your dosage accordingly.
Apidra is also available in Solostar pens and 100 u/mL vials.
Common side effects of this medication include: hypoglycemia, allergic reactions, lipodystrophy, itching, rashes and weight gain.
Skin irritations may occur at the site of injection, which includes redness, swelling, and hard lumps (lipodystrophy). To avoid this from happening, do not skip meals and monitor your blood sugar levels regularly.
It is not recommended to smoke or drink excessively, as these can impact blood sugar levels.
If you are pregnant or breastfeeding, let your doctor know before starting this treatment (see pregnancy tab for more information)
Do not use this medication if your blood sugar levels are low (hypoglycemia). Please consult your doctor if you have any heart, liver, or kidney problems before starting treatment.
Apidra 100IU Cartridge is a fast-acting form of insulin that helps manage blood sugar levels effectively by replacing the insulin that is typically produced by the body.
As a result, glucose can enter the cells for the body to use as energy. Blood glucose levels are dropped within 10-20 minutes of injection and can last up to 3-5 hours. Speak with your doctor about how to properly administer the injection for effectiveness.
Some medicines cause changes in the blood sugar level (decrease, increase, or both depending on the situation). In each case, it may be necessary to adjust your insulin dose to avoid blood sugar levels that are either too low or too high. Be careful when you start or stop taking another medicine.
Tell your doctor or pharmacist if you have recently taken or might take any other medicines. Before taking a medication, ask your doctor if it can affect your blood sugar level and what action, if any, you need to take.
Medicines that may cause your blood sugar level to fall (hypoglycemia) include:
-all other medicines to treat diabetes,
-angiotensin-converting enzyme (ACE) inhibitors (used to treat certain heart conditions or high blood pressure),
-disopyramide (used to treat certain heart conditions),
-fluoxetine (used to treat depression),
-fibrates (used to lower high levels of blood lipids),
-monoamine oxidase (MAO) inhibitors (used to treat depression),
-pentoxifylline, propoxyphene, salicylates (such as aspirin, used to relieve pain and lower fever),
Medicines that may cause your blood sugar level to rise (hyperglycemia) include:
-corticosteroids (such as “cortisone” used to treat inflammation),
-danazol (medicine acting on ovulation),
-diazoxide (used to treat high blood pressure),
-diuretics (used to treat high blood pressure or excessive fluid retention),
-glucagon (pancreas hormone used to treat severe hypoglycemia),
-isoniazid (used to treat tuberculosis),
-estrogens and progestogens (such as in the contraceptive pill used for birth control),
-phenothiazine derivatives (used to treat psychiatric disorders),
-somatropin (growth hormone),
-sympathomimetic medicines (such as epinephrine [adrenaline], salbutamol, terbutaline used to treat asthma),
-thyroid hormones (used to treat thyroid gland disorders),
-protease inhibitors (used to treat HIV),
-atypical antipsychotic medicines (such as olanzapine and clozapine).
Your blood sugar level may either rise or fall if you take:
-beta-blockers (used to treat high blood pressure),
-clonidine (used to treat high blood pressure),
-lithium salts (used to treat psychiatric disorders).
Pentamidine (used to treat some infections caused by parasites) may cause hypoglycemia which may sometimes be followed by hyperglycemia.
Beta-blockers, like other sympatholytic medicines (such as clonidine, guanethidine, and reserpine), may weaken or suppress entirely the first warning symptoms, which help you to recognize hypoglycemia. If you are not sure whether you are taking one of those medicines, ask your doctor or pharmacist.
Hypoglycemia may occur due to an excess of insulin activity relative to food intake and energy expenditure.
There are no specific data available concerning overdoses with insulin glulisine. However, hypoglycemia may develop over sequential stages.
Mild hypoglycaemic episodes can be treated by oral administration of glucose or sugary products. Therefore, it is recommended that the diabetic patient constantly carries some sugar lumps, sweets, biscuits, or sugary fruit juice.
Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 mg to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction or by glucose given intravenously by a healthcare professional. Glucose must also be given intravenously if the patient does not respond to glucagon within 10 to 15 minutes.
Upon regaining consciousness, administration of oral carbohydrates is recommended for the patient to prevent relapse.
After an injection of glucagon, the patient should be monitored in a hospital to find the reason for this severe hypoglycemia and prevent similar episodes.
There are no or limited amount of data (less than 300 pregnancy outcomes) from the use of insulin glulisine in pregnant women.
Animal reproduction studies have not revealed any differences between insulin glulisine and human insulin regarding pregnancy, embryonal/foetal development, parturition or postnatal development (see section 5.3).
Caution should be exercised when prescribing to pregnant women. Careful monitoring of glucose control is essential.
It is essential for patients with pre-existing or gestational diabetes to maintain good metabolic control throughout pregnancy. Insulin requirements may decrease during the first trimester and generally increase during the second and third trimesters. Immediately after delivery, insulin requirements decline rapidly.
It is unknown whether insulin glulisine is excreted in human milk, but in general insulin does not pass into breast milk and is not absorbed after oral administration.
Breast-feeding mothers may require adjustments in insulin dose and diet.
Animal reproduction studies with insulin glulisine have not revealed any adverse effects on fertility.
Keep this medicine out of reach from children. Keep in the refrigerator between 2-8°C and do not freeze. Keep inside the cart and away from direct light or heat
Do not use the medication if it is past the expiry date.
Do not use if medication appears colorless or clear.
Once opened, it can be stored for a maximum of 4 weeks in the outer carton
Discard within 28 days of first use
Spare cartridges should also be discarded after 28 days after being removed from the refrigerator.
When disposing of cartridges, do not throw them away in waste or down wastewater. Speak to your pharmacist about disposing of any unused medication. Best practices for disposing of medication helps protect the environment.